Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning

The role of macrolide/β-lactam combination therapy in community-acquired pneumonia (CAP) of moderate severity is a matter of debate. Macrolides expand the coverage to atypical pathogens and attenuate pulmonary inflammation, but have been associated with cardiovascular toxicity and drug interactions....

Full description

Saved in:
Bibliographic Details
Published in:The European respiratory journal Vol. 54; no. 6
Main Authors: König, Rainer, Cao, Xueqi, Oswald, Marcus, Forstner, Christina, Rohde, Gernot, Rupp, Jan, Witzenrath, Martin, Welte, Tobias, Kolditz, Martin, Pletz, Mathias
Format: Journal Article
Language:English
Published: England 01.12.2019
ISSN:1399-3003, 1399-3003
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first